ReviewCureus2024

Evaluation of the Efficacy and Safety of Anifrolumab in Moderate-to-Severe Systemic Lupus Erythematosus.

Ananya Reddy Cingireddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.